Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 6:00 AM ET

Date/Time Source News Release
12/23/2024 08:00 AM EST GlobeNewswire Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/14/2024 04:05 PM EST GlobeNewswire Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
11/13/2024 05:00 PM EST GlobeNewswire Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
10/08/2024 07:30 AM EDT GlobeNewswire Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
09/19/2024 07:00 AM EDT GlobeNewswire Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
09/18/2024 07:00 AM EDT GlobeNewswire Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
08/14/2024 04:05 PM EDT GlobeNewswire Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
08/14/2024 07:30 AM EDT GlobeNewswire Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
06/27/2024 07:30 AM EDT GlobeNewswire Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
06/12/2024 07:30 AM EDT GlobeNewswire Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
Page